BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 31837899)

  • 1. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Kidney Allograft and Recipient Survival After Liver Transplantation by Induction Type in the United States.
    Riad SM; Lim N; Jackson S; Matas AJ; Lake J
    Liver Transpl; 2021 Nov; 27(11):1553-1562. PubMed ID: 34145949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States.
    Riad S; Jackson S; Chinnakotla S; Verghese P
    Pediatr Transplant; 2021 Aug; 25(5):e13925. PubMed ID: 33333629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Kidney Transplant Outcomes in Dialysis Dependent Recipients by Induction Type in the United States.
    Swanson KJ; Bregman A; El-Rifai R; Jackson S; Kandaswamy R; Riad S
    Transplant Proc; 2023 Sep; 55(7):1535-1542. PubMed ID: 37419731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Allograft and Recipient Survival After Heart Transplantation by Induction Type in the United States.
    Riad S; Alexy T; Jackson S; Goswami U; Martin C
    Transplantation; 2022 Mar; 106(3):633-640. PubMed ID: 33741841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
    Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
    Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States.
    Riad S; Jackson S; Chinnakotla S; Verghese P
    Pediatr Transplant; 2021 Aug; 25(5):e13928. PubMed ID: 33314638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recipient and Graft Outcomes in Simultaneous Kidney and Pancreas Transplantation With Steroid Avoidance in the United States.
    Cerise A; Shaker T; LeNguyen P; Dinesh A; Jackson S; Kandaswamy R; Riad S
    Transplantation; 2023 Feb; 107(2):521-528. PubMed ID: 36195029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
    Massie AB; Orandi BJ; Waldram MM; Luo X; Nguyen AQ; Montgomery RA; Lentine KL; Segev DL
    Am J Kidney Dis; 2020 Nov; 76(5):616-623. PubMed ID: 32668318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between spousal donor transplantation treated with anti-thymocyte globulin induction therapy and, living related donor transplantation treated with standard immunosuppression.
    Demir E; Paydas S; Erken U
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):520-3. PubMed ID: 24821146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.
    Gill JS; Rose C; Joffres Y; Landsberg D; Gill J
    Am J Kidney Dis; 2018 May; 71(5):636-647. PubMed ID: 29395484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant.
    Husain SA; King KL; Sanichar N; Crew RJ; Schold JD; Mohan S
    JAMA Netw Open; 2021 Apr; 4(4):e215718. PubMed ID: 33847748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes.
    Gerbase-DeLima M; de Marco R; Monteiro F; Tedesco-Silva H; Medina-Pestana JO; Mine KL
    Front Immunol; 2020; 11():954. PubMed ID: 32528472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood group relationships to kidney transplant recipient and graft outcomes.
    Ng MSY; Ullah S; Wilson G; McDonald S; Sypek M; Mallett AJ
    PLoS One; 2020; 15(7):e0236396. PubMed ID: 32702043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
    Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.